Publications by authors named "G Maroun"

This case report presents a 38-year-old transgender woman, assigned male at birth, who presented with severe right flank pain associated with nausea and hematuria. After previously undergoing gender-affirming surgeries, including abdominoplasty, liposuction, breast augmentation, and reconstructive vaginal surgery, the patient developed bilateral ureteral and kidney stones leading to significant hydronephrosis. Bilateral double J insertion was performed following a computed tomography (CT) Uroscan.

View Article and Find Full Text PDF

Recent discoveries reveal that the chronic presence of senescent cells in osteoarticular tissues provides a focal point of disease development for osteoarthritis (OA). Nevertheless, senescence-regulatory factors associated with OA still need to be identified. Furthermore, few diagnostic- and prognostic-validated biochemical markers (biomarkers) are currently used in clinics to evaluate OA patients.

View Article and Find Full Text PDF

Vicarious menstruation refers to cyclical bleeding outside the uterine cavity during the menstrual cycle. Haemolacria, or blood in tears, is a rare medical phenomenon that can occur with menstruation or in association with endometriosis. Endometriosis, defined by the presence of endometrial-like tissue in extra-uterine sites, affects around 10% of fertile women; the ocular system is one of the rarest sites it can be present in.

View Article and Find Full Text PDF
Article Synopsis
  • The study compares balloon-assisted gastrostomy (BAG) with conventional dilator methods for inserting large bore feeding tubes.
  • Data was collected from 200 patients over two years, focusing on safety, efficiency, and complication rates between the two techniques.
  • Results showed that BAG had fewer minor complications and required less sedation, making it a safe and effective option for patients needing gastrostomy tubes.
View Article and Find Full Text PDF
Article Synopsis
  • The case series evaluates safety, efficacy, overall survival (OS), and progression-free survival (PFS) in patients with intrahepatic cholangiocarcinoma (ICC) treated with percutaneous ablation, TACE, or both treatments at a specific institution from 2013 to 2019.
  • Ten patients were analyzed: three received combined treatment (TACE and ablation), three had only TACE, and four underwent ablation. PFS and OS were tracked from diagnosis, with technical success evaluated through follow-up imaging.
  • Results indicated that most patients (9 out of 10) are alive, with median OS of 29.5 months and PFS of 15.5 months; the treatments are
View Article and Find Full Text PDF